Initiator Pharma A/S's other current liabilities is $1.7M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
The latest other current liabilities for INIT.ST is $1.7M as of June 2026. That compares with $520K in the prior-year period — up 229.1% year over year. Investors often review this figure alongside Initiator Pharma A/S's historical trend and sector peers before judging valuation or financial health.
Over the past year, INIT.ST's other current liabilities moved from $520K to $1.7M — a 229.1% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Initiator Pharma A/S's operating scale or balance-sheet position.
A other current liabilities figure of $1.7M for INIT.ST is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.
After noting INIT.ST's other current liabilities ($1.7M), review year-over-year change from $520K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack Initiator Pharma A/S's other current liabilities against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.